Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives.
about
Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a reviewSecond generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers.
P2860
Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition and breaking of adv ...... -2-aminoimidazole derivatives.
@en
type
label
Inhibition and breaking of adv ...... -2-aminoimidazole derivatives.
@en
prefLabel
Inhibition and breaking of adv ...... -2-aminoimidazole derivatives.
@en
P2093
P2860
P1433
P1476
Inhibition and breaking of adv ...... -2-aminoimidazole derivatives.
@en
P2093
Brendan K Podell
Christian Melander
David F Ackart
Jessica D Haugen
Mike A Richardson
Randall J Basaraba
Robert E Furlani
Roberta J Melander
P2860
P304
P356
10.1016/J.TETLET.2015.01.122
P577
2015-01-01T00:00:00Z